Internet Computer ICP

Bitcoin Cash BCH

Litecoin LTC

Syntara Limited

SNT

Current price

0.041 AUD -0.0041 AUD (-8.89%)

Last closed 0.043 AUD

Company –

ISIN AU0000312480

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Exchange Australian Securities Exchange

Capitalization 34 645 037 AUD

Yield for 12 month +36.67 %

10Y

15Y

SNT

21.11.2021 - 28.11.2021

Syntara Limited operates as a clinical-stage drug development company that focuses on blood-related cancers in Australia. The company's lead product candidate is SNT-5505, which is in Phase 2 trial to treat myelofibrosis, myelodysplastic syndrome, hepatocellular carcinoma, and pancreatic cancer, as well as scar prevention. It also develops SNT-4728 in Phase 2 trial for the treatment of neurodegenerative diseases comprising isolated rapid eye movement sleep behavior disorder (IRBD) and Parkinson's disease; SNT-5382, which is a selective lysyl oxidase-like 2 inhibitor in Phase 1 trial to treat chronic fibrosis; and SNT-8370 for the treatment of inflammation. The company was formerly known as Pharmaxis Ltd and changed its name to Syntara Limited in December 2023. Syntara Limited was incorporated in 1998 and is headquartered in Frenchs Forest, Australia. Address: 20A Rodborough Road, Frenchs Forest, NSW, Australia, 2086

Check your investment idea

Find the best to beat the market

TSLA Tesla Motors

AAPL Apple

MSFT Microsoft

Activate

View

Activate

View

Analytics

WallStreet Target Price

0.15 AUD

P/E ratio

–

Dividend Yield

–

Revenue
Profit

Current Year

–

Last Year

–

Current Quarter

–

Last Quarter

–

Current Year

–

Last Year

–

Current Quarter

–

Last Quarter

–

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

EBITDA -10 463 487 AUD

Operating Margin TTM -64.12 %

PE Ratio –

Return On Assets TTM -34.55 %

PEG Ratio –

Return On Equity TTM -97.62 %

Wall Street Target Price 0.15 AUD

Revenue TTM 19 185 061 AUD

Book Value –

Revenue Per Share TTM

Dividend Share –

Quarterly Revenue Growth YOY –

Dividend Yield –

Gross Profit TTM –

Earnings per share –

Diluted Eps TTM –

Most Recent Quarter IV 2023

Quarterly Earnings Growth YOY –

Profit Margin -64.84 %

Dividend growth over 5 years

–

Continuous growth

–

Payout Ratio 5 years average

–

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

Forward Annual Dividend Rate –

Ex Dividend Date –

Forward Annual Dividend Yield –

Last Split Factor –

Payout Ratio –

Last Split Date –

Dividend Date –

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

Trailing PE –

Forward PE –

Enterprise Value Revenue –

Price Sales TTM –

Enterprise Value EBITDA –

Price Book MRQ –

Financials SNT

1 year

3 years

5 years

10 years

15 years

Track key metrics for each stock in one place without the hassle

Get Premium

Results	2019	Dynamics

* The data for this period has not yet been published

0.014 AUD 0.058 AUD

50 Day MA 0.019 AUD

Shares Short Prior Month –

200 Day MA 0.021 AUD

Short Ratio –

Shares Short –

Short Percent –

	All time	January, 22	February, 22	March, 22	April, 22	May, 22	June, 22
Companies with BMS 90+	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%
Companies with BMS 60-	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%

Similar to

Syntara Limited